{"id":"W4407622522","doi":"10.1016/j.ijgc.2024.100243","title":"Patient-Reported Outcomes In Patients With Primary Advanced Or Recurrent Endometrial Cancer Treated With Chemotherapy Plus Dostarlimab Or Placebo In The ENGOT-EN6-NSGO/GOG3031/RUBY Trial Over 3 Years Of Follow-Up","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Placebo; Endometrial cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002013616,0.000642559,0.00201136,0.0002554646,0.0002403258,0.000711704,0.0004473775,0.0009018655,0.001553929],"category_scores_gemma":[0.001928772,0.0002507735,0.003057878,0.0003610099,0.0004202057,0.000671085,0.0003530895,0.00183271,0.0001883352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005006412,"about_ca_system_score_gemma":0.0004736303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0010318,"about_ca_topic_score_gemma":0.001910996,"domain_scores_codex":[0.9993151,0.0003394391,0.00005506345,0.0001155898,0.00005848296,0.0001162498],"domain_scores_gemma":[0.9991516,0.0002439346,0.0003083596,0.00005226516,0.00004854711,0.0001952084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.897172,0.003038363,0.04490087,0.001457057,0.01223655,0.0001572207,0.0001177907,0.001824334,0.002578193,0.0001454008,0.001502145,0.03487014],"study_design_scores_gemma":[0.3824671,0.2256587,0.3598158,0.0004099636,0.02277557,0.0003663855,0.0002726304,0.00280098,0.001277157,0.0005895004,0.003452327,0.0001139141],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863924,0.01110632,0.0001319034,0.000289118,0.0001579162,0.0001275845,0.000859,0.00001462017,0.0009210383],"genre_scores_gemma":[0.9962776,0.001699445,0.0001018705,0.0002491866,0.00009846385,0.0001451402,0.0009405689,0.000003024163,0.0004847351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002013616,"threshold_uncertainty_score":0.01064909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02350707287604202,"score_gpt":0.3328067624310174,"score_spread":0.3092996895549753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}